Two metalloproteinases, ADAM metallopeptidase domain 19 (ADAM19) and matrix metallopeptidase 9 (MMP9), upregulated under hypoxia, are also associated with cancer progression, mainly through modulation of cell adhesion and migration in several cancers, including NSCLC [70,71,72,73]. This evidence concerns the gene ADAM19 and cancer.